TY - JOUR KW - addiction treatment KW - buprenorphine KW - Buprenorphine/therapeutic use KW - Capacity Building/organization & administration KW - Evidence-based practice implementation KW - Family Practice/education KW - Health Personnel/education KW - Humans KW - medication-assisted treatment KW - Naltrexone KW - Naltrexone/therapeutic use KW - Narcotic Antagonists/therapeutic use KW - Opiate Substitution Treatment/methods KW - Opioid-Related Disorders/therapy KW - Organizational Innovation KW - Psychiatry/education KW - Research Design KW - Staff Development/organization & administration KW - Telemedicine/organization & administration KW - United States KW - Workflow AU - T. Molfenter AU - H. K. Knudsen AU - R. Brown AU - N. Jacobson AU - J. Horst AU - M. Van Etten AU - J. S. Kim AU - E. Haram AU - E. Collier AU - S. Starr AU - A. Toy AU - L. Madden A1 - BT - Implementation science : IS C5 - Opioids & Substance Use; Education & Workforce CP - 1 CY - England DO - 10.1186/s13012-017-0665-x IS - 1 JF - Implementation science : IS PP - England PY - 2017 SN - 1748-5908; 1748-5908 SP - 135 T1 - Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial T2 - Implementation science : IS TI - Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial U1 - Opioids & Substance Use; Education & Workforce U2 - 29141653 U3 - 10.1186/s13012-017-0665-x VL - 12 VO - 1748-5908; 1748-5908 Y1 - 2017 ER -